Drug · DIN 02429810
LORAZEPAM
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 6, 2016; first marketed March 12, 2015.
- Drug Identification Number (DIN)
- 02429810
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Targeted substances (cdsa iv)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lorazepam N05BA06
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LORAZEPAM | 1 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 28, 2014: NOC 16010New Drug Submission (NDS) · Licensing agreement between two companies
Other DINs named LORAZEPAM
- DIN 02351072 · Cancelled Post Market
- DIN 02351080 · Cancelled Post Market
- DIN 02351099 · Cancelled Post Market
- DIN 02429802 · Cancelled Pre Market
- DIN 02429829 · Cancelled Post Market